Superior HealthPlan Invests $18M in OTC Items for Texas Members
Superior HealthPlan Invests $18 Million in Over-the-Counter Items to Support Health Needs of Medicaid and CHIP Members Across Texas Superior HealthPlan, a leading managed care organization in Texas and a subsidiary of Centene Corporation , has announced a major milestone…
CVS Health Joins White House Initiative for Patient-Centered Health Tech
CVS Health Commits $20 Billion to Advance Patient-Centric Technology as It Joins White House-Backed Health Tech Initiative CVS Health has announced its formal participation in a major new initiative launched by the White House and the Centers for Medicare &…
Alcon to Acquire STAAR Surgical in Strategic Expansion Move
Alcon to Acquire STAAR Surgical in $1.5 Billion Deal to Expand Refractive Surgery Portfolio In a significant move to enhance its surgical vision correction offerings, Alcon a global leader in eye care, has announced its intention to acquire STAAR Surgical…
American Cancer Society, Guardant Health Partner to Expand Cancer Screening Access
American Cancer Society and Guardant Health Forge Strategic Partnership to Expand Cancer Screening and Tackle Health Disparities Nationwide The American Cancer Society has announced a strategic partnership with Guardant Health , a leading precision oncology company, to improve access to…
Dallah Healthcare Reports Record Quarterly Revenue, H1 Net Profit Up 21%
Dallah Healthcare Reports Record-Setting Q2 Revenue Surpassing SAR 1 Billion, Driven by Strategic Acquisitions and Operational Growth; H1 Net Profit Climbs 21% Dallah Healthcare, a leading integrated healthcare provider in Saudi Arabia, has announced its financial results for the second…
Exicure Completes Final Patient Visit in Phase 2 Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma
Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last patient, last visit in its ongoing Phase 2 clinical trial (NCT05561751) evaluating the safety and efficacy of GPC-100 (burixafor) in…
Turiya Anesthesia to Launch Services at Emanate Health Foothill Presbyterian Hospital
Turiya Anesthesia, a leading provider of high-quality anesthesia services in Southern California, is thrilled to announce the expansion of its partnership with Emanate Health to now include Foothill Presbyterian Hospital located at 250 South Grand Ave, Glendora, California. Building on…
Oral Cancer Rapid Test Kits Market 2024–2030: Insights into Emerging Diagnostic Technologies
Global Oral Cancer Rapid Test Kits Market to Reach $1.2 Billion by 2030, Driven by Technological Innovation and Early Diagnosis Demand ResearchAndMarkets.com has released the “Oral Cancer Rapid Test Kits – Global Strategic Business Report,” providing detailed insights into a…
Broc Shot Becomes the First Supplement to Receive the Seal of Recognition From the National Psoriasis Foundation
Broc Shot Becomes the First Supplement to Receive the Seal of Recognition From the National Psoriasis Foundation Broc Shot is the first supplement to earn the Seal of Recognition from the National Psoriasis Foundation (NPF). This recognition highlights Broc Shot’s support for skin health from…
Spine BioPharma Reports Phase 3 Topline Results for SB-01 in Chronic Low Back Pain Due to Degenerative Disc Disease
Spine BioPharma, Inc. announced today the Phase 3 MODEL trial (MOderate – Severe Degenerative Disc Disease Evaluation of the Lumbar Spine) evaluating SB-01, a TGF-β antagonist for intradiscal treatment of patients with Chronic Low Back Pain (CLBP) associated with Degenerative Disc Disease (DDD), did…
Performant Healthcare, Inc. to Be Acquired by Machinify
Performant Healthcare, Inc. (Nasdaq: PHLT) (the “Company” or “Performant”), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio…
Behcet’s Disease Market 2025–2035: AbbVie, Novartis, Roche, J&J, BMS Lead Biologics Growth
The “Behcet’s Disease Market – A Global and Regional Analysis: Focus on Distribution Channel, Route of Administration, Type, Country, and Region – Analysis and Forecast, 2025-2035″ report has been added to ResearchAndMarkets.com’s offering. The global Behcet’s disease market is highly competitive, characterized by the…